Posted inTechnology News Lunit AI Demonstrates Accuracy in Practical Assessment of Cancer Tissue-Findings to Be … Posted by 21 March 2022 As a leading medical AI provider, Lunit focuses on developing novel AI biomarkers for application in cancer treatment. Since 2019, the company has … View All Posts Post navigation Previous Post When is it safe to discontinue TKI therapy in people with chronic myeloid leukemia? – MedCity NewsNext PostNew Zealand’s COVID-19 shared care record creates GP outcry as cases soar | Healthcare IT News